当前位置: 首页 >> 检索结果
共有 5002 条符合本次的查询结果, 用时 2.1140645 秒

4481. Nivolumab with or without Relatlimab in Untreated Advanced Melanoma. Reply.

作者: Hussein A Tawbi.;F Stephen Hodi.;Georgina V Long.
来源: N Engl J Med. 2022年386卷19期1860-1861页

4482. Nivolumab with or without Relatlimab in Untreated Advanced Melanoma.

作者: Elif Hindié.
来源: N Engl J Med. 2022年386卷19期1860页

4483. Audio Interview: Forecasting the Future of Covid.

作者: Eric J Rubin.;Lindsey R Baden.;Marc Lipsitch.;Stephen Morrissey.
来源: N Engl J Med. 2022年386卷19期e58页

4484. Lenacapavir for HIV-1 - Potential Promise of a Long-Acting Antiretroviral Drug.

作者: Jeanne Marrazzo.
来源: N Engl J Med. 2022年386卷19期1848-1849页

4485. Case 14-2022: A 57-Year-Old Man with Chylous Ascites.

作者: Michael Dougan.;Mark A Anderson.;Jeremy S Abramson.;Megan J Fitzpatrick.
来源: N Engl J Med. 2022年386卷19期1834-1844页

4486. Emphysematous Aortitis.

作者: Edward C Traver.;Nina J Gao.
来源: N Engl J Med. 2022年386卷19期1833页

4487. Preeclampsia.

作者: Laura A Magee.;Kypros H Nicolaides.;Peter von Dadelszen.
来源: N Engl J Med. 2022年386卷19期1817-1832页

4488. Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection.

作者: Sorana Segal-Maurer.;Edwin DeJesus.;Hans-Jurgen Stellbrink.;Antonella Castagna.;Gary J Richmond.;Gary I Sinclair.;Krittaecho Siripassorn.;Peter J Ruane.;Mezgebe Berhe.;Hui Wang.;Nicolas A Margot.;Hadas Dvory-Sobol.;Robert H Hyland.;Diana M Brainard.;Martin S Rhee.;Jared M Baeten.;Jean-Michel Molina.; .
来源: N Engl J Med. 2022年386卷19期1793-1803页
Patients with multidrug-resistant human immunodeficiency virus type 1 (HIV-1) infection have limited treatment options. Lenacapavir is a first-in-class capsid inhibitor that showed substantial antiviral activity in a phase 1b study.

4489. Climate Change in the Supreme Court.

作者: Lisa Heinzerling.
来源: N Engl J Med. 2022年386卷24期2255-2257页

4490. Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age.

作者: C Buddy Creech.;Evan Anderson.;Vladimir Berthaud.;Inci Yildirim.;Andrew M Atz.;Ivan Melendez Baez.;Daniel Finkelstein.;Paul Pickrell.;Judith Kirstein.;Clifford Yut.;Ronald Blair.;Robert A Clifford.;Michael Dunn.;James D Campbell.;David C Montefiori.;Joanne E Tomassini.;Xiaoping Zhao.;Weiping Deng.;Honghong Zhou.;Daniela Ramirez Schrempp.;Kelly Hautzinger.;Bethany Girard.;Karen Slobod.;Roderick McPhee.;Rolando Pajon.;Rituparna Das.;Jacqueline M Miller.;Sabine Schnyder Ghamloush.; .
来源: N Engl J Med. 2022年386卷21期2011-2023页
Vaccination of children to prevent coronavirus disease 2019 (Covid-19) is an urgent public health need. The safety, immunogenicity, and efficacy of the mRNA-1273 vaccine in children 6 to 11 years of age are unknown.

4491. Navigating Loss of Abortion Services - A Large Academic Medical Center Prepares for the Overturn of Roe v. Wade.

作者: Lisa H Harris.
来源: N Engl J Med. 2022年386卷22期2061-2064页

4492. BNT162b2 Protection against the Omicron Variant in Children and Adolescents. Reply.

作者: Ashley M Price.;Samantha M Olson.;Manish M Patel.
来源: N Engl J Med. 2022年386卷24期2346页

4493. BNT162b2 Protection against the Omicron Variant in Children and Adolescents.

作者: Guangting Zeng.
来源: N Engl J Med. 2022年386卷24期2345-2346页

4494. Retinal Hemorrhages in Leukemia.

作者: Gladys R Rodrigues.;Teena M Mendonca.
来源: N Engl J Med. 2022年386卷19期e50页

4495. Unmute.

作者: Margaret Nolan.
来源: N Engl J Med. 2022年386卷19期1777-1779页

4496. Supporting Innovation in Medicaid Policy - Interventions to Increase Adoption of RCTs.

作者: Jacob Wallace.;Julia Smith.;Atheendar Venkataramani.
来源: N Engl J Med. 2022年386卷19期1775-1777页

4497. Your Money or Your Life - The High Cost of Cancer Drugs under Medicare Part D.

作者: Stacie B Dusetzina.
来源: N Engl J Med. 2022年386卷23期2164-2167页

4498. A Comprehensive Covid-19 Response - The Need for Economic Evaluation.

作者: Govind Persad.;Ankur Pandya.
来源: N Engl J Med. 2022年386卷26期2449-2451页

4499. Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine.

作者: Karen J Hager.;Gonzalo Pérez Marc.;Philipe Gobeil.;Ricardo S Diaz.;Gretchen Heizer.;Conrado Llapur.;Alexander I Makarkov.;Eduardo Vasconcellos.;Stéphane Pillet.;Fernando Riera.;Pooja Saxena.;Priscila Geller Wolff.;Kapil Bhutada.;Garry Wallace.;Hessam Aazami.;Christine E Jones.;Fernando P Polack.;Luciana Ferrara.;Judith Atkins.;Iohann Boulay.;Jiwanjeet Dhaliwall.;Nathalie Charland.;Manon M J Couture.;Julia Jiang-Wright.;Nathalie Landry.;Sophie Lapointe.;Aurélien Lorin.;Asif Mahmood.;Lawrence H Moulton.;Emmy Pahmer.;Julie Parent.;Annie Séguin.;Luan Tran.;Thomas Breuer.;Maria-Angeles Ceregido.;Marguerite Koutsoukos.;François Roman.;Junya Namba.;Marc-André D'Aoust.;Sonia Trepanier.;Yosuke Kimura.;Brian J Ward.; .
来源: N Engl J Med. 2022年386卷22期2084-2096页
Coronavirus-like particles (CoVLP) that are produced in plants and display the prefusion spike glycoprotein of the original strain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are combined with an adjuvant (Adjuvant System 03 [AS03]) to form the candidate vaccine.

4500. Pembrolizumab in Early Triple-Negative Breast Cancer. Reply.

作者: Peter Schmid.;Javier Cortes.;Rebecca Dent.
来源: N Engl J Med. 2022年386卷18期1771-1772页
共有 5002 条符合本次的查询结果, 用时 2.1140645 秒